Sunshine Biopharma, Inc. (SBFM) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Sunshine Biopharma, Inc. (SBFM) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $931,099, listed on NASDAQ, employing roughly 50 people, carrying a beta of 1.31 to the broader market. Sunshine Biopharma, Inc. Led by Steve N. Slilaty, public since 2022-02-15.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for SBFM as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →